PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PABG.L vs. XLVP.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


PABG.LXLVP.L
YTD Return7.47%7.94%
1Y Return16.58%11.62%
3Y Return (Ann)2.77%6.66%
Sharpe Ratio1.251.22
Sortino Ratio1.791.85
Omega Ratio1.211.21
Calmar Ratio1.891.12
Martin Ratio5.675.39
Ulcer Index2.66%2.34%
Daily Std Dev12.13%10.37%
Max Drawdown-26.49%-17.58%
Current Drawdown-4.20%-4.58%

Correlation

-0.50.00.51.00.5

The correlation between PABG.L and XLVP.L is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

PABG.L vs. XLVP.L - Performance Comparison

In the year-to-date period, PABG.L achieves a 7.47% return, which is significantly lower than XLVP.L's 7.94% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
0.72%
4.75%
PABG.L
XLVP.L

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PABG.L vs. XLVP.L - Expense Ratio Comparison

PABG.L has a 0.20% expense ratio, which is higher than XLVP.L's 0.14% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


PABG.L
Lyxor Net Zero 2050 S&P Eurozone Climate PAB (DR) UCITS ETF - Acc
Expense ratio chart for PABG.L: current value at 0.20% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.20%
Expense ratio chart for XLVP.L: current value at 0.14% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.14%

Risk-Adjusted Performance

PABG.L vs. XLVP.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Lyxor Net Zero 2050 S&P Eurozone Climate PAB (DR) UCITS ETF - Acc (PABG.L) and Invesco US Health Care Sector UCITS ETF (XLVP.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PABG.L
Sharpe ratio
The chart of Sharpe ratio for PABG.L, currently valued at 1.50, compared to the broader market-2.000.002.004.001.50
Sortino ratio
The chart of Sortino ratio for PABG.L, currently valued at 2.14, compared to the broader market-2.000.002.004.006.008.0010.0012.002.14
Omega ratio
The chart of Omega ratio for PABG.L, currently valued at 1.26, compared to the broader market1.001.502.002.503.001.26
Calmar ratio
The chart of Calmar ratio for PABG.L, currently valued at 1.43, compared to the broader market0.005.0010.0015.001.43
Martin ratio
The chart of Martin ratio for PABG.L, currently valued at 8.11, compared to the broader market0.0020.0040.0060.0080.00100.00120.008.11
XLVP.L
Sharpe ratio
The chart of Sharpe ratio for XLVP.L, currently valued at 1.90, compared to the broader market-2.000.002.004.001.90
Sortino ratio
The chart of Sortino ratio for XLVP.L, currently valued at 2.70, compared to the broader market-2.000.002.004.006.008.0010.0012.002.70
Omega ratio
The chart of Omega ratio for XLVP.L, currently valued at 1.33, compared to the broader market1.001.502.002.503.001.33
Calmar ratio
The chart of Calmar ratio for XLVP.L, currently valued at 1.83, compared to the broader market0.005.0010.0015.001.83
Martin ratio
The chart of Martin ratio for XLVP.L, currently valued at 8.15, compared to the broader market0.0020.0040.0060.0080.00100.00120.008.15

PABG.L vs. XLVP.L - Sharpe Ratio Comparison

The current PABG.L Sharpe Ratio is 1.25, which is comparable to the XLVP.L Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of PABG.L and XLVP.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.50
1.90
PABG.L
XLVP.L

Dividends

PABG.L vs. XLVP.L - Dividend Comparison

Neither PABG.L nor XLVP.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PABG.L vs. XLVP.L - Drawdown Comparison

The maximum PABG.L drawdown since its inception was -26.49%, which is greater than XLVP.L's maximum drawdown of -17.58%. Use the drawdown chart below to compare losses from any high point for PABG.L and XLVP.L. For additional features, visit the drawdowns tool.


-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-6.45%
-5.51%
PABG.L
XLVP.L

Volatility

PABG.L vs. XLVP.L - Volatility Comparison

Lyxor Net Zero 2050 S&P Eurozone Climate PAB (DR) UCITS ETF - Acc (PABG.L) has a higher volatility of 5.19% compared to Invesco US Health Care Sector UCITS ETF (XLVP.L) at 2.56%. This indicates that PABG.L's price experiences larger fluctuations and is considered to be riskier than XLVP.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
5.19%
2.56%
PABG.L
XLVP.L